Provisio Medical Technologies Corp has raised $9.8M in total funding. The most recent round was Seed.
Provisio Medical Technologies Corp is headquartered in San Diego, CA.
Peripheral Artery Disease affects 200M people with a mortality rate worse than most cancers, yet current diagnostics (angiograms and traditional IVUS) underestimate vessel size, are underused, and can't measure blood flow during a procedure.
Provisio is developing the SLT Platform, an automated smart-catheter system designed to size, map, confirm, and assess treatment success, including SLT FLOW for intra-procedural volumetric blood flow measurement.
The site claims SLT FLOW is the world's first and only catheter-based volumetric blood flow measurement, cites FDA Breakthrough Device Designation as pending, and notes a new ICD-10 code it says no competitor can bill.
Founded by Dr. S. Eric Ryan, a former Volcano Corporation VP, Provisio Medical develops intravascular ultrasound smart-catheter technology and has raised tens of millions in venture funding, including backing tied to MedTech Innovator.
Free to use in articles, research, and reference works. Stable URL, will not change. Data on this page last updated August 26, 2026.